Clinical Trials Logo

Clinical Trial Summary

Recurrent pregnancy loss is classically defined as the occurrence of three or more consecutive pregnancy loss. The American Society of Reproductive Medicine has recently redefined recurrent pregnancy loss as two or more pregnancy losses. A pregnancy loss is defined as a clinically-recognized pregnancy means that the pregnancy has been visualized on an ultrasound or that pregnancy tissue was identified after a pregnancy loss.


Clinical Trial Description

Spontaneous pregnancy loss is a surprisingly common occurrence. Whereas approximately 15% of all clinically recognized pregnancies result in spontaneous loss, there are many more pregnancies that fail prior to being clinically recognized. Only 30% of all conceptions result in a live birth.

Although no reliable published data have estimated the probability of finding an etiology for recurrent pregnancy loss in a population with 2 versus 3 or more miscarriages, the best available data suggest that the risk of miscarriage in subsequent pregnancies is 30% after 2 losses, compared with 33% after 3 losses among patients without a history of a live birth. This strongly suggests a role for evaluation after just 2 losses in patients with no prior live births. An earlier evaluation may be further indicated if fetal cardiac activity was identified prior to a loss . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03267771
Study type Interventional
Source Assiut University
Contact Ahmed Ibrahim
Phone 01000024321
Email ahmedibrahimhas@yahoo.com
Status Not yet recruiting
Phase Phase 4
Start date October 1, 2017
Completion date December 5, 2019

See also
  Status Clinical Trial Phase
Terminated NCT04056637 - Choice of Modality of Follow up for Medication Abortion N/A
Active, not recruiting NCT05896657 - Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713 N/A
Active, not recruiting NCT03736681 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage Phase 1
Completed NCT03636451 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o Phase 3
Completed NCT04446572 - Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin Phase 2
Recruiting NCT05341817 - The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy Phase 4
Completed NCT03079622 - Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks N/A
Recruiting NCT05182008 - A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial N/A
Completed NCT03417362 - Delivery of Audiovisual Information on Early Medical Abortion N/A
Completed NCT03896022 - Auriculotherapy - Pain Management of Aspiration Abortion N/A
Completed NCT03925129 - Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation N/A
Suspended NCT03751423 - Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion Phase 3
Completed NCT03480009 - Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion Phase 3
Completed NCT05469594 - Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Enrolling by invitation NCT05320432 - Transcutaneous Electrical Nerve Stimulation for Pain Control During First-trimester Abortion N/A
Completed NCT03187002 - Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion N/A
Terminated NCT04139382 - Using Telemedicine to Improve Early Medical Abortion at Home N/A
Recruiting NCT04956731 - Pharmacist Provision of Medication Abortion N/A
Recruiting NCT04336358 - Telemedicine for First Trimester Abortion in South Africa N/A
Completed NCT02096575 - Nitrous Oxide for Pain Management of First Trimester Surgical Abortion N/A